(Q37311131)

19 August 2017

1 reference

title

Induction, function and regulation of IL-17-producing T cells (English)

1 reference

19 August 2017

Kingston H G Mills

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

European Journal of Immunology

19 August 2017

published in

1 reference

19 August 2017

volume

38

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

2636-2649

1 reference

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Stat3 and Stat4 direct development of IL-17-secreting Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Interleukin-17 and lung host defense against Klebsiella pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Regulation of virus-induced IL-12 and IL-23 expression in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

Regulatory T cells: key controllers of immunologic self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Regulatory T cells: friend or foe in immunity to infection?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

The biological functions of T helper 17 cell effector cytokines in inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Phenotypic and functional features of human Th17 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Transforming growth factor-beta induces development of the T(H)17 lineage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

T cell dependence of chronic destructive murine arthritis induced by repeated local activation of toll-like receptor–driven pathways: Crucial role of both interleukin-1β and interleukin-17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Development, cytokine profile and function of human interleukin 17-producing helper T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Distinct regulation of interleukin-17 in human T helper lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

How microorganisms tip the balance between interleukin-12 family members

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-17 receptor signaling influences virus-induced corneal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838535

7 January 2021

Identifiers

DOI

10.1002/EJI.200838535

1 reference

19 August 2017

1 reference